[go: up one dir, main page]

FR2702211B1 - Nouveaux dérivés de la phénoxy-2 éthylamine, leur préparation et leur application en thérapeutique. - Google Patents

Nouveaux dérivés de la phénoxy-2 éthylamine, leur préparation et leur application en thérapeutique.

Info

Publication number
FR2702211B1
FR2702211B1 FR9302502A FR9302502A FR2702211B1 FR 2702211 B1 FR2702211 B1 FR 2702211B1 FR 9302502 A FR9302502 A FR 9302502A FR 9302502 A FR9302502 A FR 9302502A FR 2702211 B1 FR2702211 B1 FR 2702211B1
Authority
FR
France
Prior art keywords
phenoxyethylamine
preparation
therapeutic use
new derivatives
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9302502A
Other languages
English (en)
Other versions
FR2702211A1 (fr
Inventor
Bernard Bonnaud
Florence Castan
Dennis Bigg
Wouter Koek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9302502A priority Critical patent/FR2702211B1/fr
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Priority to EP94908368A priority patent/EP0687252A1/fr
Priority to CA002152400A priority patent/CA2152400A1/fr
Priority to PCT/FR1994/000202 priority patent/WO1994020466A1/fr
Priority to AU61435/94A priority patent/AU6143594A/en
Priority to JP6519644A priority patent/JPH08507302A/ja
Priority to ZA941532A priority patent/ZA941532B/xx
Publication of FR2702211A1 publication Critical patent/FR2702211A1/fr
Application granted granted Critical
Publication of FR2702211B1 publication Critical patent/FR2702211B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
FR9302502A 1993-03-04 1993-03-04 Nouveaux dérivés de la phénoxy-2 éthylamine, leur préparation et leur application en thérapeutique. Expired - Fee Related FR2702211B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR9302502A FR2702211B1 (fr) 1993-03-04 1993-03-04 Nouveaux dérivés de la phénoxy-2 éthylamine, leur préparation et leur application en thérapeutique.
CA002152400A CA2152400A1 (fr) 1993-03-04 1994-02-24 Nouveaux derives de la phenoxy-2 ethylamine, leur preparation et leur application en therapeutique
PCT/FR1994/000202 WO1994020466A1 (fr) 1993-03-04 1994-02-24 Nouveaux derives de la phenoxy-2 ethylamine, leur preparation et leur application en therapeutique
AU61435/94A AU6143594A (en) 1993-03-04 1994-02-24 Novel 2-phenoxy ethylamine derivatives, their preparation and their therapeutical use
EP94908368A EP0687252A1 (fr) 1993-03-04 1994-02-24 Derives de la phenoxy-2 ethylamine, leur preparation et leur application en therapeutique
JP6519644A JPH08507302A (ja) 1993-03-04 1994-02-24 新規な２−フェノキシエチルアミン誘導体、その調製およびその治療への使用
ZA941532A ZA941532B (en) 1993-03-04 1994-03-04 Novel 2-}henoxyethylamine derivatives their preparation and their application in therapeutics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9302502A FR2702211B1 (fr) 1993-03-04 1993-03-04 Nouveaux dérivés de la phénoxy-2 éthylamine, leur préparation et leur application en thérapeutique.

Publications (2)

Publication Number Publication Date
FR2702211A1 FR2702211A1 (fr) 1994-09-09
FR2702211B1 true FR2702211B1 (fr) 1995-06-02

Family

ID=9444650

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9302502A Expired - Fee Related FR2702211B1 (fr) 1993-03-04 1993-03-04 Nouveaux dérivés de la phénoxy-2 éthylamine, leur préparation et leur application en thérapeutique.

Country Status (7)

Country Link
EP (1) EP0687252A1 (fr)
JP (1) JPH08507302A (fr)
AU (1) AU6143594A (fr)
CA (1) CA2152400A1 (fr)
FR (1) FR2702211B1 (fr)
WO (1) WO1994020466A1 (fr)
ZA (1) ZA941532B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA58476C2 (uk) * 1997-10-09 2003-08-15 Санофі-Сентелябо Похідні 8-азабіцикло[3.2.1]октан-3-метанаміну, фармацевтична композиція та лікарський засіб
FR2769629B1 (fr) * 1997-10-09 1999-11-12 Synthelabo Derives de 8-azabicyclo[3.2.1]octane-3-methanamine, leur preparation et leur application en therapeutique
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
FR2786767B1 (fr) * 1998-12-02 2001-02-23 Pf Medicament Nouveaux derives de 3-alkoxybenzylamines et leur utilisation a titre de medicaments pour le traitement de la schizophrenie
FR2791676B1 (fr) * 1999-03-29 2001-06-22 Pf Medicament Nouveaux derives de [(2-substitue-5-[thienyl])-benzyl]- [2-([isopropoxy-5-fluoro]-phenoxy) ethyl]-amine, leur procede de preparation et leur utilisation a titre de medicaments
EP3260452A1 (fr) * 2016-06-24 2017-12-27 Neurolixis Composes pour le traitement des troubles sensibles à la serotonine commande par the recepteurs 5-ht1a

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658823B1 (fr) * 1990-02-27 1992-04-30 Adir Nouveaux derives d'aminomethylpiperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent .
EP0522914A1 (fr) * 1991-06-27 1993-01-13 Synthelabo Dérivés de 2-pipéridinylpyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique

Also Published As

Publication number Publication date
WO1994020466A1 (fr) 1994-09-15
ZA941532B (en) 1994-10-06
EP0687252A1 (fr) 1995-12-20
JPH08507302A (ja) 1996-08-06
CA2152400A1 (fr) 1994-09-15
AU6143594A (en) 1994-09-26
FR2702211A1 (fr) 1994-09-09

Similar Documents

Publication Publication Date Title
FR2696176B1 (fr) Dérivés de pipéridine, leur préparation et leur application en thérapeutique.
FR2711993B1 (fr) Médicaments contenant des dérivés de 7H-imidazol[1,2-a]pyrazine-8-one, les nouveaux composés et leur préparation.
FR2710915B1 (fr) Dérivés de pipéridine, leur préparation et leur utilisation en thérapeutique.
FR2769915B1 (fr) Derives d'indazole tricycliques, leur preparation et leur application en therapeutique
FR2713234B1 (fr) Nouveaux dérivés de la triphénodioxazine, leur préparation et leur utilisation comme pigments.
FR2756563B1 (fr) Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-yl- methyle, leur preparation et leur application en therapeutique
FR2705671B1 (fr) Nouveaux dérivés de l'hydroxybiphényle, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2712289B1 (fr) Nouveaux dérivés de taxicine, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2696177B1 (fr) Dérivés de pipéridine, leur préparation et leur application en thérapeutique.
FR2717811B1 (fr) Dérivés d'imidazo[1,2-a]pyrazine-4-one, leur préparation et les médicaments les contenant.
FR2702211B1 (fr) Nouveaux dérivés de la phénoxy-2 éthylamine, leur préparation et leur application en thérapeutique.
FR2701479B1 (fr) Nouveaux dérivés hétérocycliques de l'aminométhyl-4 pipéridine, leur préparation et leur application en thérapeutique.
FR2699920B1 (fr) Dérivés d'imidazo [2,1-b] benzothiazole-3-acétamide, leur préparation et leur application en thérapeutique.
FR2700546B1 (fr) Dérivés d'imidazo[2,1-b]benzoxazole-3-acétamide, leur préparation et leur application en thérapeutique.
FR2753196B1 (fr) Derives d'indazole tricyclique, leur preparation et leur application en therapeutique
FR2697253B1 (fr) Dérivés de 2-aminopyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.
FR2693197B1 (fr) Nouveaux dérivés de quinoléine, leur procédé de préparation et leur application thérapeutique.
FR2719844B1 (fr) Dérivés de 5,6-dihydro-4h-thiéno[3,4-c]pyrrole, leur préparation et leur application en thérapeutique.
FR2769914B1 (fr) Derives d'indazole tricycliques leur preparation et leur application en therapeutique
FR2703355B1 (fr) Dérivés de 2-aminopyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.
FR2699534B1 (fr) Dérivés de alpha-thiényl-pipéridine-1-éthanol, leur préparation et leur application en thérapeutique.
FR2699174B1 (fr) Dérivés de 3-(quinoléin-6-yl-méthyl)-4H-imidazol-4-one, leur préparation et leur application en thérapeutique.
FR2698364B1 (fr) Dérivés de pyrrole, leur préparation et leur application en thérapeutique.
FR2693194B1 (fr) Dérivés d'alcanecarboxamide, leur préparation et leur application thérapeutique.
FR2700543B1 (fr) Sels de dérivés de 4-pyrimidinone, leur préparation et leur application en thérapeutique.

Legal Events

Date Code Title Description
ST Notification of lapse